THE EFFICIENCY FRONTIER APPROACH TO ECONOMIC EVALUATION OF HEALTH-CARE INTERVENTIONS

被引:83
作者
Caro, J. Jaime [1 ,2 ]
Nord, Erik [3 ]
Siebert, Uwe [4 ]
McGuire, Alistair [5 ]
McGregor, Maurice [2 ]
Henry, David [6 ]
de Pouvourville, Gerard [7 ]
Atella, Vincenzo [8 ]
Kolominsky-Rabas, Peter [9 ]
机构
[1] United Biosource Corp, Lexington, MA 02420 USA
[2] McGill Univ, Montreal, PQ, Canada
[3] Norwegian Inst Publ Hlth, Oslo, Norway
[4] UMIT Univ Hlth Sci Med Informat & Technol, Hall In Tirol, Austria
[5] London Sch Econ, London WC2A 2AE, England
[6] Univ Newcastle, ICES, Callaghan, NSW 2308, Australia
[7] ESSEC Business Sch, Cergy, France
[8] Univ Roma Tor Vergata, Rome, Italy
[9] IQWiG, Cologne, Germany
关键词
efficiency; health policy; health technology assessment; economic evaluation; reimbursement; Germany; QALYS; LIFE; PAY;
D O I
10.1002/hec.1629
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background: IQWiG commissioned an international panel of experts to develop methods for the assessment of the relation of benefits to costs in the German statutory health-care system. Proposed methods: The panel recommended that IQWiG inform German decision makers of the net costs and value of additional benefits of an intervention in the context of relevant other interventions in that indication. To facilitate guidance regarding maximum reimbursement, this information is presented in an efficiency plot with costs on the horizontal axis and value of benefits on the vertical. The efficiency frontier links the interventions that are not dominated and provides guidance. A technology that places on the frontier or to the left is reasonably efficient, while one falling to the right requires further justification for reimbursement at that price. This information does not automatically give the maximum reimbursement, as other considerations may be relevant. Given that the estimates are for a specific indication, they do not address priority setting across the health-care system. Conclusion: This approach informs decision makers about efficiency of interventions, conforms to the mandate and is consistent with basic economic principles. Empirical testing of its feasibility and usefulness is required. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:1117 / 1127
页数:11
相关论文
共 41 条
[1]  
[Anonymous], 1996, COST EFFECTIVENESS H, DOI DOI 10.1093/OSO/9780195108248.001.0001
[2]  
[Anonymous], 2003, EUR J HLTH EC, DOI DOI 10.1007/S10198-003-0205-2
[3]  
[Anonymous], METH ASS REL BEN COS
[4]   The value of DALY life: problems with ethics and validity of disability adjusted life years [J].
Arnesen, T ;
Nord, E .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7222) :1423-1425
[5]   EFFICIENCY FRONTIER DETERMINATION BY CONSTRAINED FACET ANALYSIS [J].
BESSENT, A ;
BESSENT, W ;
ELAM, J ;
CLARK, T .
OPERATIONS RESEARCH, 1988, 36 (05) :785-796
[6]   COST-EFFECTIVENESS UTILITY ANALYSES - DO CURRENT DECISION RULES LEAD US TO WHERE WE WANT TO BE [J].
BIRCH, S ;
GAFNI, A .
JOURNAL OF HEALTH ECONOMICS, 1992, 11 (03) :279-296
[7]   THE CE PLANE - A GRAPHIC REPRESENTATION OF COST-EFFECTIVENESS [J].
BLACK, WC .
MEDICAL DECISION MAKING, 1990, 10 (03) :212-214
[8]   QALYS [J].
BROOME, J .
JOURNAL OF PUBLIC ECONOMICS, 1993, 50 (02) :149-167
[9]  
*BUND GES, 2009, STELL METH KOST NUTZ
[10]  
*BUND JUST, 2007, GES STARK WETTB GES